Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Express Scripts
AstraZeneca
Dow
Baxter

Last Updated: January 16, 2022

Volunteer for clinical trials for ADDERALL XR 5 at ClinicalTrialExchange

DrugPatentWatch Database Preview

ADDERALL XR 5 Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Adderall Xr 5, and what generic alternatives are available?

Adderall Xr 5 is a drug marketed by Takeda Pharms Usa and is included in one NDA.

The generic ingredient in ADDERALL XR 5 is amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. There are fifty-five drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate profile page.

Drug patent expirations by year for ADDERALL XR 5
Recent Clinical Trials for ADDERALL XR 5

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of California, Los AngelesEarly Phase 1
University of WyomingPhase 2
National Institute on Drug Abuse (NIDA)Phase 4

See all ADDERALL XR 5 clinical trials

US Patents and Regulatory Information for ADDERALL XR 5

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Takeda Pharms Usa ADDERALL XR 5 amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021303-005 May 22, 2002 AB RX Yes No ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial ⤷  Sign up for a Free Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ADDERALL XR 5

International Patents for ADDERALL XR 5

Country Patent Number Estimated Expiration
European Patent Office 1977736 ⤷  Sign up for a Free Trial
Canada 2348090 ⤷  Sign up for a Free Trial
Japan 2002527468 ⤷  Sign up for a Free Trial
Germany 69940673 ⤷  Sign up for a Free Trial
Australia 1214500 ⤷  Sign up for a Free Trial
European Patent Office 1123087 ⤷  Sign up for a Free Trial
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Baxter
AstraZeneca
Medtronic
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.